Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline demographics, medical history and clinical characteristics of patients (n = 100)

From: Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study

  All (n = 100)
Age (years) 64.38 ± 7.05
Male n/N, (%) 62/100 (62%)
Body Mass Index (kg/m2) 26.5 ± 4.72
Body Surface Area (m2) 1.73 ± 0.18
NYHA functional class
 I 5/98(5.1%)
 II 51/98(52.04%)
 III 39/98(39.8%)
 IV 3/98(3.06%)
Sinus rhythm 97/100 (97%)
Comorbidities
 Hypertension 51/100 (51%)
 Coronary Artery Disease 38/100 (38%)
 Non aortic Valve Disease 29/100 (29%)
 Diabetes mellitus 38/100 (38%)
 Hyperlipidemia 3/100 (3%)
 Renal Insufficiency 2/100 (2%)
 Congestive Heart Failure 2/100 (2%)
 Stroke 1/100 (1%)
 Transient Ischemic Attack 2/100 (2%)
 Myocardial Infarction 1/100 (1%)
Previous coronary artery intervention 4/100 (4%)
Previous CABG 7/100 (7%)
Permanent pacemaker 1/100 (1%)
Aortic Valve Pathology
 Degenerative calcification 54/100 (54%)
 Bicuspid 42/100 (42%)
 Rheumatic 14/100 (14%)
 Endocarditis 1/100 (1%)
 Structural deterioration 1/100 (1%)
 Other 4/100 (4%)
Aortic Valve Lesion
 Insufficiency 7/100 (7%)
 Stenosis 68/100 (68%)
 Mixed 25/100 (25%)
  1. n Total number of patients, kg/m2 Kilogram/meter2